Analystreport

Bellus Health Inc. (NYSE: BLU) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock.

BELLUS Health Inc. - Common Shares  (BLU) 
Last bellus health inc. - common shares earnings: 11/14 07:00 am Check Earnings Report